本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BioRestorative Therapies, Inc.

1.78
+0.02001.14%
盤後1.800.0200+1.12%16:00 EDT
成交量:1.19萬
成交額:2.14萬
市值:1,335.85萬
市盈率:-1.54
高:1.81
開:1.79
低:1.77
收:1.76
資料載入中...
2024/04/03

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/30

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2023/11/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/16

重要事件披露

Form 8-K - Current report
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/13

重要事件披露

Form 8-K - Current report
2023/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/14

重要事件披露

8-K - Current report
2023/04/06

重要事件披露

8-K - Current report
2023/03/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]